SMPV Limited
  • Home
  • About
  • Services
  • Pharmacovigilance
  • Resources
  • Speaking and Events
  • FAQ
  • Contact Us
  • More
    • Home
    • About
    • Services
    • Pharmacovigilance
    • Resources
    • Speaking and Events
    • FAQ
    • Contact Us
SMPV Limited
  • Home
  • About
  • Services
  • Pharmacovigilance
  • Resources
  • Speaking and Events
  • FAQ
  • Contact Us

pharmacovigilance expertise

SMPV Limited provides senior pharmacovigilance consulting focused on inspection readiness, governance, MAH oversight, and system control. Our work supports pharmaceutical and biotech organisations in demonstrating clarity, control, and confidence across their PV systems under EMA, MHRA, and FDA expectations.

Always‑Ready PV Framework

A Modern Approach to Pharmacovigilance System Governance

1. What the Always‑Ready PV Framework Is


The Always‑Ready PV Framework  is a structured approach to pharmacovigilance system governance designed to ensure year‑round inspection readiness through clarity, control, and confidence.


2.  What Regulators Expect


Regulators increasingly assess whether organisations understand how their PV system operates in practice, can demonstrate clear ownership and escalation, maintain consistent oversight across vendors, and document decisions coherently.


3. Common Weaknesses We See


Across inspections, we routinely see fragmented governance, unclear delegated responsibilities, mismatch between documented and operational systems, scattered evidence, and PSMFs that do not reflect reality.


4. What the Framework Delivers


Clear system maps and RACIs, predictable governance cadence, aligned vendor oversight, coherent inspection narratives, and sustainable, defensible compliance



Our Services

We offer services based on your journey. Discover our services based on your needs and inspection status (whether announced/confirmed or not). 

Learn More

Inspection Readiness

A Complete Guide for EMA, MHRA & FDA Expectations

1. What Inspection Readiness Means in Practice


Inspection readiness means being able to explain, evidence, and defend how the PV system works — without disruption — when challenged by EMA, MHRA, or FDA inspectors.


2. What Inspectors Actually Assess


Inspectors focus on governance effectiveness, decision‑making and escalation, MAH oversight of vendors, PSMF accuracy, and consistency across interviews, documents, and systems.


3. Typical Inspection Failure Patterns


Common findings include inconsistent SME answers, undocumented decisions, vendors operating outside defined controls, reactive oversight, and PSMFs disconnected from day‑to‑day practice.


4. How SMPV Limited Supports Readiness


SMPV supports inspection readiness through inspection‑style stress testing, interview rehearsal, evidence retrieval testing, governance stabilisation, and narrative alignment.


Our Approach

Whether you are expecting an inspection or not, inspection readiness starts with you. From process and system designs to improvements, evaluate your level of compliance now.

Get Started

Vendor Oversight & Governance

How to Build a High‑Control, Low‑Friction Oversight Model

1. Why Vendor Oversight Fails


Oversight failures rarely result from intent; they arise from weak governance, over‑reliance on vendor reporting, unclear escalation rules, and misalignment between contracts, SOPs, and practice.


2. What Regulators Expects from MAHs


Regulators expect MAHs to retain demonstrable control, actively monitor delegated activities, identify and act on risks, and evidence oversight decisions.

   

3. Common Oversight Weaknesses


Collected KPIs not acted upon, subcontractor arrangements not fully understood, governance meetings without follow‑up, and oversight records that do not support inspection narratives.


4. SMPV Limited’s Oversight Model


SMPV Limited supports MAHs through structured governance design, escalation clarity, KPI frameworks, vendor alignment reviews, and inspection‑focused evidence optimisation.


5. Outcomes

  • Reduced inspection risk
  • Predictable vendor performance
  • Transparent accountability
  • Stronger MAH control
  • Clear, defensible evidence trails

Control review

End-to-end process review allows a holistic evaluation of your system for strong governance and compliance.

Start now

PSMF Guide

Clarity, Coherence & Operational Reality

1. Why PSMFs Become Inspection Risks


Many PSMFs fail because they describe intended processes rather than real ones, lag behind system changes, under‑describe governance, and omit how decisions are made.


2. What a Coherent PSMF Looks Like


A strong PSMF accurately reflects operational practice, clearly describes governance, aligns vendor roles with MAH oversight, and supports consistent inspection narratives.


3. Common PSMF Issues We See


Outdated vendor lists, unclear delegation rules, missing governance documentation, contradictory process descriptions, and weak linkage to evidence.


4. SMPV Limited’s PSMF Coherence Review


Our review focuses on system mapping, governance reconciliation, operational alignment, inspection‑style challenge, and practical recommendations for sustainable updates.



Be Ready

Start with a quick snap shot review of the document to assess areas of improvements and risks straight away. 

Start your Review

GLOSSARY

Pharmacovigilance System

Pharmacovigilance System

Pharmacovigilance System

The pharmacovigilance system is the complete set of processes, roles, governance, and controls through which a Marketing Authorisation Holder (MAH) fulfils its ongoing responsibilities for the safety of authorised medicinal products.


Further reference to the EU GVP Definition can be found her: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-annex-i-definitions-rev-5_en.pdf

Inspection Readiness

Pharmacovigilance System

Pharmacovigilance System

Inspection readiness in pharmacovigilance means the ability of an organisation to demonstrate, at any time, that its PV system is understood, controlled, and operating as described, across internal teams and all external stakeholders including business partners and contracted vendors.

MAH Oversight

Pharmacovigilance System

Vendor Oversight

MAH oversight refers to the retained responsibility of the Marketing Authorisation Holder to actively govern, monitor, and control all pharmacovigilance activities, including those delegated to third parties: business partners, vendors or subcontractors.

Vendor Oversight

PSMF (Pharmacovigilance System Master File)

Vendor Oversight

Vendor oversight is the structured framework by which the MAH ensures delegated pharmacovigilance activities are performed in accordance with regulatory requirements, contractual obligations, and the MAH’s own PV system design. This includes subcontracted activities by vendors.

PSMF (Pharmacovigilance System Master File)

PSMF (Pharmacovigilance System Master File)

PSMF (Pharmacovigilance System Master File)

The PSMF is the formal description of the pharmacovigilance system and must accurately reflect how the system actually operates, including governance structures, processes and delegated activities associated with the pharmacovigilance system. 


For the EU GVP Definition, refer to:

https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-annex-i-definitions-rev-5_en.pdf

PSMF Coherence

PSMF (Pharmacovigilance System Master File)

PSMF (Pharmacovigilance System Master File)

PSMF coherence describes the degree to which the PSMF aligns with real operational practice. A coherent PSMF is consistent with the established Pharmacovigilance System, governance decisions, SOPs, vendor and business partners roles, and inspection narratives.

Governance Cadence

Governance Cadence

Governance Cadence

Governance cadence is the regular, documented rhythm through which pharmacovigilance decisions, oversight activities, escalation, and risk management are conducted and controlled.

Micro‑Failures

Governance Cadence

Governance Cadence

Micro‑failures are small but systemic weaknesses in PV systems — such as unclear ownership, undocumented decisions, or inconsistent oversight — that individually appear minor but cumulatively lead to inspection findings.

  • Services
  • FAQ
  • Contact Us
  • Cookies Policy
  • Terms of Website Use
  • Website privacy notice

SMPV Limited

London, United Kingdom

Copyright © 2026 SMPV Limited - All Rights Reserved.

SMPV LIMITED is a limited company registered in England and Wales.
Registered number: 11388233
Registered office: 241 Mitcham Road, Tooting, London, England, SW17 9JQ

This website uses cookies.

We use strictly essential cookies. You may disable cookies, but please note that some parts of this website may become inaccessible or not function properly. 

Accept

Take your inspection readiness to the next level.

Complete the scorecard to assess your readiness and have an immediate feedback on areas to improve.

The Plug-In Strategy.

Compliance That Fits, Confidence That Lasts. 

take the scorecard